X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
administration, intranasal (4) 4
cpe-215 (4) 4
humans (4) 4
adolescent (3) 3
adult (3) 3
cross-over studies (3) 3
cyclopentadecalactone (3) 3
dose-response relationship, drug (3) 3
hypoglycemic agents - administration & dosage (3) 3
hypoglycemic agents - adverse effects (3) 3
hypoglycemic agents - pharmacokinetics (3) 3
insulin - administration & dosage (3) 3
insulin - adverse effects (3) 3
insulin - pharmacokinetics (3) 3
intranasal insulin (3) 3
nasulin (3) 3
young adult (3) 3
absorption (2) 2
chemistry, pharmaceutical (2) 2
feasibility studies (2) 2
health (2) 2
middle aged (2) 2
nasal sprays (2) 2
nose (2) 2
placebos (2) 2
time factors (2) 2
ultrarapid time-action profile (2) 2
absorption - drug effects (1) 1
absorption enhancers (1) 1
analgesic efficacy (1) 1
animals (1) 1
antibody (1) 1
area under curve (1) 1
blood glucose - drug effects (1) 1
chemistry, multidisciplinary (1) 1
chisys (1) 1
chisystm (1) 1
clearance characteristics (1) 1
controlled release (1) 1
criticalsorb (1) 1
criticalsorbtm (1) 1
cyclopentanes - administration & dosage (1) 1
cyclopentanes - adverse effects (1) 1
cyclopentanes - pharmacokinetics (1) 1
drug carriers - administration & dosage (1) 1
drug carriers - pharmacokinetics (1) 1
drug delivery systems (1) 1
drugs (1) 1
female (1) 1
formulations (1) 1
insulin (1) 1
intranasal delivery (1) 1
intravail (1) 1
male (1) 1
morphine-chitosan (1) 1
nasal absorption promoters (1) 1
nasal mucosa - drug effects (1) 1
nasal mucosa - metabolism (1) 1
original (1) 1
original articles (1) 1
pecsys (1) 1
pecsystm (1) 1
pharmacology & pharmacy (1) 1
polyols (1) 1
safety (1) 1
system (1) 1
the present review sets out to discuss recent developments and prospectsof absorption promoters and absorption modulator systems being developedcommercially by companies specialising in nasal drug delivery of normal small molecular weight drugs and biological drugs such as peptide and proteins. the absorption promoter systems selected for discussion in this review are those with the most promising preclinical and/or clinical data and sufficient toxicology data and/or company development efforts to warrant use in marketed products i.e. cpe-215 (1) 1
ultra-rapid time action profile (1) 1
vehicles (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.